1.
Efficacy of Empagliflozin versus Dapagliflozin in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial. Glob. J. Med. Pharm. Sci. 2023;1(3):09-16. Accessed June 25, 2026. http://www.globapc.com/index.php/gjmps/article/view/28